Raloxifene Hydrochloride Tablets, USP, 60 mg, 30 Tablets (3 x 10 blister cards), Rx Only, Package...

FDA Recall #D-0854-2020 — Class II — December 4, 2019

Recall #D-0854-2020 Date: December 4, 2019 Classification: Class II Status: Terminated

Product Description

Raloxifene Hydrochloride Tablets, USP, 60 mg, 30 Tablets (3 x 10 blister cards), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-266-21; NDC Unit Dose: 60687-266-11

Reason for Recall

Failed Dissolution Specifications: Low out of specification results obtained during stability testing.

Recalling Firm

American Health Packaging — Columbus, OH

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

973 cartons

Distribution

Nationwide within the United States

Code Information

Lot #:180276A, Exp date 02/29/2020

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated